20/20 Biolabs Inc

NAS:AIDXHealthcarenasdaq_composite

$0.2603−0.12%At closeAt close · Tue 20 Oct · ≈ AED 0.9560 · Market cap $3.32M · Next earnings Wed 2 Dec

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	37.6%	48.8%	46.3%	7.7%	20.6%	29.6%	—	—
Operating margin	−87.1%	20.2%	15.2%	−446.6%	−323.1%	−162.9%	−162.9%	+0.0 pts
Net margin	−86.8%	21.5%	19.8%	−448.7%	−316.8%	−182.8%	−182.8%	+0.0 pts
EBITDA margin	−84.3%	21.5%	17.8%	−434.9%	−315.3%	−171.4%	—	—
Return on equity	−59.7%	30.1%	23.3%	−149.1%	−361.9%	19.4%	19.4%	+0.0 pts
Return on assets	−43.2%	20.2%	17.9%	−100.4%	−153.7%	−0.1%	−0.1%	+0.0 pts
Return on capital employed	−59.2%	24.2%	15.9%	−118.8%	−250.7%	−0.2%	—	—
Debt / equity	0.0×	0.3×	0.3×	0.5×	1.0×	−66.8×	−66.8×	+0.0%
Debt / assets	3.1%	22.9%	19.8%	32.5%	41.9%	31.0%	—	—
Interest coverage	0.0×	150.2×	107.0×	−227.9×	−447.7×	−21.3×	—	—
Current ratio	3.1×	3.5×	6.0×	4.3×	1.5×	0.6×	0.6×	+0.0%
Quick ratio	3.0×	3.4×	5.9×	4.2×	1.5×	0.6×	—	—
Cash ratio	2.8×	1.5×	5.4×	4.0×	1.3×	0.4×	0.4×	+0.0%
Asset turnover	0.5×	0.9×	0.9×	0.2×	0.5×	0.0×	—	—
Inventory turnover	14.1×	20.0×	68.2×	21.7×	29.5×	0.0×	—	—
Receivables turnover	11.4×	2.3×	14.5×	20.7×	13.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.